<DOC>
	<DOCNO>NCT00643279</DOCNO>
	<brief_summary>The purpose clinical research study evaluate safety investigational implantable hemodynamic monitor ( IHM ) . The IHM implant surgically skin upper chest area record force heart pump blood ( heart pressure ) . This study also determine doctor use information relate heart pressure management heart failure .</brief_summary>
	<brief_title>Chronicle Offers Management Patients With Advanced Signs Symptoms Heart Failure ( COMPASS-HF )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<criteria>Subjects heart failure classify New York Heart Association ( NYHA ) Class III IV Subject manage standard medical therapy heart failure ( diuretic , angiotensinconverting enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARB ) , betablocker least 3 month prior baseline evaluation Subject must least one heart failurerelated hospitalization emergency department visit require intravenous treatment within 6 month prior baseline evaluation Subjects likely transplant within 6 month randomization remain hospitalized transplantation Subjects severe COPD restrictive airway disease ( recommend FEV1 less equal 1 liter 50 % predict ) Subjects continuous positive inotropic therapy Subjects know atrial ventricular septal defect Subjects mechanical right heart valves Subjects stenotic tricuspid pulmonary valve Subjects presently implant noncompatible pacemaker ICD Subjects cardiac resynchronization therapy achieve optimal program 3 month Subjects major cardiovascular event within 3 month prior baseline evaluation Subjects severe noncardiac condition limit 6 month survival Subjects primary diagnosis pulmonary artery hypertension Subjects serum creatinine great equal 3.5 mg/dL chronic renal dialysis Subjects enrol concurrent study may confound result study Women pregnant child bear potential reliable form birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>implantable hemodynamic monitor</keyword>
	<keyword>Intracardiac pressure</keyword>
</DOC>